 LEXINGTON, Mass.--BUSINESS WIRE--Cyteir Therapeutics, Inc. Cyteir Nasdaq: CYT, a company focused on the discovery and development of next-generation synthetically lethal therapies for cancer, today announced that its President and Chief Executive Officer, Markus Renschler, MD, will participate in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference on September 14, 2022. Morgan Stanley 20th Annual Global Healthcare Conference Date: Wednesday, September 14 Time: 